SciELO - Scientific Electronic Library Online

 
vol.81 issue4Alopecia areata and trichotillomania as anxiety repercussions in a childSuccessful surgical treatment of hypertrophic genital herpes in HIV-infected patient author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • Have no similar articlesSimilars in SciELO

Share


Portuguese Journal of Dermatology and Venereology

Print version ISSN 2795-501XOn-line version ISSN 2795-5001

Port J Dermatol Venereol. vol.81 no.4 Lisboa Dec. 2023  Epub Sep 01, 2023

https://doi.org/10.24875/pjdv.23000048 

CASE REPORT

Pityriasis lichenoides et varioliformis acuta-like secondary syphilis: a case report of a rare cutaneous presentation

Relato de um caso de sífilis secundária com apresentação cutânea rara tipo pitiríase liquenóide e varioliforme aguda

Miguel Nogueira1  *  https://orcid.org/0000-0001-7420-408X

Ema Pos2 

André Coelho3 

Mónica Caetano1 

Joel Reis1  https://orcid.org/0000-0002-8007-2420

1Department of Dermatology

2Department of Infectious Diseases

3Department of Pathology. Centro Hospitalar Universitário de Santo António, Porto, Portugal


Abstract

The diagnosis of secondary syphilis can be challenging for clinicians due to its diversified cutaneous presentations. This is particularly true for human immunodeficiency virus (HIV) coinfected patients, who may develop unusual clinical manifestations. We report a case of a 33-year-old male, with HIV-1 infection without treatment, who presented to the emergency department (ED) with a 3-month history of erythematous macules. In the week before presenting to the ED, the lesions had progressed to multiple generalized papulovesicles and papules with central necrosis and serohemorrhagic crust, some exhibiting a “collarette” scale. Nasal discharge, earache, and fever were also present. The clinical picture was compatible with the diagnosis of pityriasis lichenoides et varioliformis acuta (PLEVA). Complementary examinations confirmed the diagnosis of PLEVA-like secondary syphilis, and the patient was successfully treated with benzathine penicillin. Our case highlights the importance of being aware of this rare cutaneous presentation of syphilis.

Keywords Syphilis; Secondary syphilis; Pityriasis lichenoides et varioliformis acuta; Case report

Resumo

O diagnóstico de sífilis secundária pode ser particularmente desafiante para os clínicos na sua prática diária dada a sua diversidade de apresentações clínicas, sobretudo nos doentes coinfetados com o VIH, que se caracterizam por manifestações cutâneas particularmente atípicas. Reportamos o caso de um homem com 33 anos de idade, com antecedentes pessoais de infeção por VIH-1 sem tratamento, e que recorreu ao serviço de urgência com quadro com 3 meses de evolução de máculas eritematosas que progrediram na última semana para múltiplas pápulovesículas e pápulas com necrose central e crosta sero-hemorrágica sobreposta, algumas delas com descamação “em colarete”, associado a sintomas sistémicos de rinorreia, otalgia e febre. Os achados clínicos eram sugestivos de tratar-se de uma pitiríase liquenóide e varioliforme aguda (PLEVA). O estudo complementar confirmou o diagnóstico de sífilis secundária e o paciente foi tratado com sucesso com toma única de penicilina benzatínica. Este caso reforça a importância do reconhecimento desta forma rara de apresentação cutânea da sífilis secundária.

Palavras-chave Sífilis; Sífilis secundária; Pitiríase liquenóide e varioliforme aguda; Caso clínico

Introduction

Syphilis is an infectious disease caused by Treponema pallidum that has long been known for its heterogeneous clinical presentation1. If untreated, it can progress through four distinct stages: primary, secondary, latent, and tertiary1. Diagnosing secondary syphilis can be particularly challenging in daily practice due to its diversified skin manifestations. It is historically known as “the great imitator” since it can mimic several other conditions such as psoriasis, lichen planus, folliculitis, or pityriasis lichenoides chronica1. In addition, unusual clinical manifestations of syphilis are more common in human immunodeficiency virus (HIV)-positive patients2. To highlight a particularly rare form of presentation, with few cases well-reported in the literature3-5, we present a case of pityriasis lichenoides et varioliformis acuta (PLEVA)-like secondary syphilis in a HIV-positive patient.

Clinical case

A 33-year-old male presented to the emergency department (ED) with a 3-month history of a skin rash that started with generalized erythematous macules. In the week before presenting to the ED, the lesions had progressed to multiple generalized papulovesicles and papules with central necrosis and serohemorrhagic crusts, some exhibiting a “collarette” scale, with no pain or pruritus. There was concomitant nasal discharge, earache, and fever, with no mucosal lesions. The patient referred that the lesions had appeared after an occasional job at a poultry farm. He denied high-risk behavior for sexually transmitted infections (STI) but mentioned a bisexual behavior.

Regarding his medical history, the patient had been diagnosed with HIV-1 infection 5 years before but then missed all subsequent appointments and abandoned treatment. A month and a half before the observation in the ED, he had returned for a follow-up of HIV infection. His viral load was 33.900 copies/mL and CD4 lymphocyte count was 632/mm3 serologic tests for syphilis (venereal disease research laboratory [VDRL] test and chemiluminescence assay [CLIA]) were all negative. He did not return to initiate antiretroviral therapy.

Physical examination demonstrated multiple generalized infiltrated erythematous papules, papulovesicles, and plaques, predominantly on the face and dorsum, with a varioliform-like appearance (Fig. 1A and B). Several lesions had already ulcerated and were covered with a serohemorrhagic crust, resembling a “tache-noir”. Some of the rounded lesions presented a “collarette” scale, particularly on his back (Fig. 2A) and feet (Fig. 2B). No mucosal lesions were identified in the oral, genital, or anal regions. There was also generalized lymphadenopathy. The clinical hypothesis of PLEVA, rickettsiosis, disseminated fungal infection, and syphilis was considered.

Figure 1 A and B: skin presentation on the face and dorsum. Multiple erythematous papules and papulovesicles, some of which have already a necrotic center and are covered by a serohemorrhagic crust. 

Figure 2 A and B: skin presentation on the dorsum and feet. Rounded brown-to-red papules covered by a “collarette” scale. 

A skin biopsy revealed interface dermatitis with a predominantly superficial lymphohistiocytic infiltrate, compatible with the suggested diagnosis of PLEVA. Serologies (Rickettsia, hepatitis B, and hepatitis C virus), and tissue culture (for mycobacteria and fungi) excluded other relevant infections. Both treponemal and non-treponemal tests were positive (VDRL 1:256; CLIA positive). Since the previous blood sample (1 month and a half before) was still preserved in the laboratory, the VDRL test was repeated, after dilution, to exclude a prozone effect, and was negative. Immunohistochemical staining using polyclonal antibodies anti-T. pallidum (MAD-000624QD from Master in vitro, Sevilla, Spain) in skin tissue revealed the presence of multiple spirochetes on the epidermis and dermis, predominantly surrounding the superficial vessels (Fig. 3).

Figure 3 Detection of Treponema pallidum using immunohistochemical technique. Multiple spirochetes (black arrow) were detected on the epidermis and dermis using polyclonal antibodies directed against T. pallidum in paraffin-embebbed skin biopsy samples. The spirochetes were predominantly deposited around the vessels, particularly the superficial plexus (immunohistochemistry with anti-T. pallidum antibody × 200). 

The diagnosis of PLEVA-like early secondary syphilis was assumed, and a single dose of 2.4 million units of intramuscular benzathine penicillin was prescribed. The patient later revealed that he occasionally engaged in transactional sex with men. The remaining workup did not reveal any other STI (Chlamydia Trachomatis, Neisseria Gonorrhoeae, hepatitis B and C viruses). He returned after 3 months, with near-complete resolution of skin lesions and negative VDRL titers. We were lost to follow-up after failing four scheduled appointments.

Discussion

Dermatologists and other clinicians should be aware of the high diversity of syphilis’ clinical presentation and this awareness seems to be more important than ever when we look through the current data on the epidemiology of the disease. In spite of not being as common as other STIs, syphilis is a systemic condition with an increasing frequency over the last decade6,7. Indeed, a recently published report by the European Center for Disease Prevention and Control revealed that although there has been a deceleration in the escalation of syphilis cases compared to the period of 2010-2017 (with annual rates ≤ 7.0/100,000 population), the incidence of confirmed syphilis cases in 2019 surpassed that of preceding years, reaching a rate of 7.4/100,000 population8. The majority of cases in high-income countries occur in men who have sex with men, with a considering proportion of these patients having a HIV coinfection2,9. The diagnosis of syphilis in patients coinfected with HIV poses a clinical challenge due to their heightened susceptibility to develop atypical cutaneous manifestations2.

PLEVA is a rare cutaneous inflammatory condition more frequent in young adults and children10. The pathogenesis of the condition remains poorly understood-several theories have been suggested, including a hypersensitivity reaction that represents an aberrant immune response to bacterial, viral, or protozoal infections10. It typically presents as an acute and recurrent skin eruption with a predilection for the trunk, skin flexures, and proximal extremities-and with no mucosal involvement10. It is characterized by multiple papules and papulovesicles that rapidly evolve to central necrosis and serohemorrhagic crusts10. Occasionally, patients can experience some infectious symptoms, usually before skin lesions. Some patients might develop a Mucha-Habermann disease - de novo or as a progression from a pre-existing PLEVA -, which seems to be an intensified version of PLEVA, with a more severe clinical presentation and associated symptoms11.

Regarding our case, the fact that our patient had a past medical history of an uncontrolled HIV infection and of unprotected sexual intercourse led us to think of the possibility of an atypical presentation of secondary syphilis. The ulcerated pustular eruption as a variant of secondary syphilis-higher intensity reported in HIV-coinfected patients-that can mimetize PLEVA describes this case perfectly. The non-occurrence of Jarisch-Herxheimer reaction led us to avoid the historical nomenclature “malignant syphilis” to describe this case of secondary syphilis. In the authors’ opinion, it is plausible that certain cases reported in the literature as PLEVA or Mucha-Habermann in HIV patients could potentially represent the ulcerated pustular eruption of secondary syphilis, which might lead clinicians to be misled by a false-negative VDRL test.

The fact that he mentioned a 3-month evolution of skin lesions, but had negative serologic tests (both VDRL and CLIA) for syphilis 1 month and a half after the beginning of the cutaneous rash is interesting, and should be discussed, but remains to be completely understood. We could have had a prozone phenomenon on VDRL, but a false-negative in a CLIA test occurs in < 1% of the cases12. With that being said, we assumed an early secondary syphilis, with two main possibilities that might justify the whole picture: (1) skin lesions had < 3 months of evolution-several reports of simultaneous manifestations of primary and secondary syphilis in HIV patients, which shortens the time to for the appearance of secondary syphilis’ cutaneous manifestations; (2) or there was another cause for the initial multiple erythematous macules that was not detected in the emergency room or on the following outpatient appointment.

All these findings and discussion highlight the need for clinicians to be aware of this differential diagnosis, to be excluded when there is a context that makes it plausible. Furthermore, it reinforces the fact that secondary syphilis might have several cutaneous presentations, particularly in HIV patients, and dermatologists have an extremely important role in reducing the impact of the disease in our community with the right treatment.

Conclusion

In conclusion, heightened awareness of the various clinical forms of syphilis is imperative for clinicians, particularly dermatologists. This awareness is amplified by the escalating prevalence of syphilis despite its relative rarity compared to other STIs - recent epidemiological data, including a report from the European Center for Disease Prevention and Control, underscores the persistent increase in syphilis cases, with a considering proportion of those patients being HIV-coinfected individuals. Ultimately, this clinical case emphasizes the pivotal role of dermatologists in effectively addressing diverse presentations of syphilis within our community.

REFERENCES

1. Lautenschlager S. Cutaneous manifestations of syphilis :recognition and management. Am J Clin Dermatol. 2006;7:291-304. [ Links ]

2. Karp G, Schlaeffer F, Jotkowitz A, Riesenberg K. Syphilis and HIV co-infection. Eur J Intern Med. 2009;20:9-13. [ Links ]

3. D'Elia Zanella LG, Lellis RF, Khoury Z, Oyafuso LK, Figueiredo-Mello C. Rupioid lesions, PLEVA and superposition phenomenon in malignant syphilis:two case reports in HIV-infected patients. J Eur Acad Dermatol Venereol. 2018;32:e91-2. [ Links ]

4. Pastuszczak M, Wozniak W, Jaworek AK, Wojas-Pelc A. Pityriasis lichenoides-like secondary syphilis and neurosyphilis in a HIV-infected patient. Postepy Dermatol Alergol. 2013;30:127-30. [ Links ]

5. Zhang M, Yu J, Huang H, Zhou C, Zhai Z, You Y, et al. Secondary syphilis in a 12-year-old girl misdiagnosed as pityriasis lichenoides et varioliformis acuta:a case report. Clin Cosmet Investig Dermatol. 2021;14:815-20. [ Links ]

6. Spicknall IH, Kreisel KM, Weinstock HS. Estimates of the prevalence and incidence of syphilis in the United States, 2018. Sex Transm Dis. 2021;48:247-52. [ Links ]

7. Zheng Y, Yu Q, Lin Y, Zhou Y, Lan L, Yang S, et al. Global burden and trends of sexually transmitted infections from 1990 to 2019:an observational trend study. Lancet Infect Dis. 2022;22:541-51. [ Links ]

8. European Centre for Disease Prevention and Control. Syphilis. In:ECDC. Annual Epidemiological Report for 2019. Stockholm:ECDC;2022. Available from:https://www.ecdc.europa.eu/en/publications-data/syphilis-annual-epidemiological-report-2019Links ]

9. Hook EW 3rd, Peeling RW. Syphilis control-a continuing challenge. N Engl J Med 2004;351:122-4. [ Links ]

10. Bowers S, Warshaw EM. Pityriasis lichenoides and its subtypes. J Am Acad Dermatol 2006;55:557-72. [ Links ]

11. Teklehaimanot F, Gade A, Rubenstein R. Pityriasis lichenoides et varioliformis acuta (PLEVA). In:StatPearls. Treasure Island, FL:StatPearls Publishing;2023. Available from:https://www.ncbi.nlm.nih.gov/books/NBK585135Links ]

12. Satyaputra F, Hendry S, Braddick M, Sivabalan P, Norton R. The laboratory diagnosis of syphilis. J Clin Microbiol. 2021;59:e0010021. [ Links ]

FundingNone.

Ethical disclosures

Protection of human and animal subjects. The authors declare that no experiments were performed on humans or animals for this study.

Confidentiality of data. The authors declare that they have followed the protocols of their work center on the publication of patient data.

Right to privacy and informed consent. The authors have obtained the written informed consent of the patients or subjects mentioned in the article. The corresponding author is in possession of this document.

Use of artificial intelligence for generating text. The authors declare that they have not used any type of generative artificial intelligence for the writing of this manuscript, nor for the creation of images, graphics, tables, or their corresponding captions.

Received: June 04, 2023; Accepted: July 29, 2023

*Correspondence: Miguel Nogueira E-mail: miguel.o.nogueira@gmail.com

Conflicts of interest

None.

Creative Commons License Portuguese Society of Dermatology and Venereology. Published by Permanyer. This is an open access article under the CC BY-NC-ND license